Shin Nippon Biomedical Laboratories : SNBL will give a preclinical seminar in Taiwan
January 17, 2019 at 10:24 pm EST
Share
We will host a joint seminar with Taiwan Research-Based Biopharmaceutical Manufacturers Association (TRPMA) in Taipei on January 23, 2019.
Up to now, drug development in Taiwan has largely operated based on manufacturing contracts; however, successful new drug development has seen an increase in active support from Taiwanese government policy.
SNBL will give lectures to Taiwanese pharmaceutical and biotech companies with the aim of shedding light on the current situation in Japan including topics such as the conduct of GLP studies and GLP monitoring authority in Japan, preclinical studies on biologics and advanced therapy products, and application of imaging techniques to pharmacology and toxicity studies.
This seminar will work to enhance mutual understanding and exchange ideas between Japan and Taiwan in order to facilitate drug development activities in both countries.
Attachments
Original document
Permalink
Disclaimer
Shin Nippon Biomedical Laboratories Ltd. published this content on 18 January 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 18 January 2019 03:23:02 UTC
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.